Can a Light-Based device spot dangerous infection risk without a blood draw?

NCT ID NCT06323447

Ongoing Diagnosis Sponsor: Leuko Labs, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial evaluates a new device called PointCheck that aims to detect severe neutropenia—a dangerous drop in infection-fighting white blood cells—without needing a blood sample. The study includes about 210 people with diffuse large B-cell lymphoma or multiple myeloma who are receiving chemotherapy that carries a risk of neutropenia. Researchers will compare the device's readings to standard blood tests to see how accurate, reliable, and easy to use it is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PointCheck, a non-invasive diagnostic device that uses light to detect severe neutropenia without a blood draw
What this could lead to: If successful, this device could offer a quick, needle-free way to monitor white blood cell counts, potentially reducing infections and hospital visits for cancer patients.
What could go wrong: The device is still being validated, and its accuracy may not match standard blood tests. It is intended as a preliminary screening tool, not a replacement for lab tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIFFUSE LARGE B-CELL LYMPHOMA MULTIPLE MYELOMA

Contacts and locations

Locations

Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States
Hospital Universitario 12 de Octubre

Madrid, 28041, Spain
MDA

Houston, Texas, 77030, United States
Massachussetts General Hospital

Boston, Massachusetts, 02114, United States
Norton Healthcare Cancer Center

Louisville, Kentucky, 40241, United States
University of Hawaii Cancer Center

Honolulu, Hawaii, 96813, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.